Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...
from NDTV News - Topstories https://ift.tt/35BsWI9
via IFTTT
from NDTV News - Topstories https://ift.tt/35BsWI9
via IFTTT
Comments
Post a Comment